eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Stocks-SABS-SAB Biotherapeutics Inc

SAB Biotherapeutics Inc SABS

‎$‎3.70-0.19(-4.88%)(1D)
Delayed prices by NASDAQin USD
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Price Target
13.00
Based on analysts who covered SABS
Invest in SAB Biotherapeutics Inc
Today
Create an eToro account to buy SABS stock on a secure, user-friendly, multi-asset trading platform.
Buy SAB Biotherapeutics Inc
SAB Biotherapeutics Inc SABS

SABS Stock Price Chart

‎-4.39‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset stable trend

The SAB Biotherapeutics Inc share price is stable this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The SAB Biotherapeutics Inc share price today is ‎$‎3.70, reflecting a ‎-4.88‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of SABS is ‎$‎282.92M with an average volume in the last three months of 771723.97. The stock has a P/E ratio of -1.5 and a dividend yield of 0%. With the stock’s beta sitting at 0.63
SABS Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎282.92M

Day’s Range
i
Shows the high and low prices of the day.
‎$‎3.58 - ‎$‎3.84

52W Range
i
Shows the high and low prices of the last year.
‎$‎3.41 - ‎$‎5.04

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
771723.97

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-1.5

Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎0

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎3.7

EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-2.47

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.63

How can I buy SAB Biotherapeutics Inc stocks?

To purchase SAB Biotherapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the SAB Biotherapeutics Inc (SABS) page and place an order to buy SAB Biotherapeutics Inc.
Looking for more information? Check out our guide on Academy.
What Is SAB Biotherapeutics Inc?
SAB Biotherapeutics Inc is a United States-based biopharmaceutical company developing novel human antibody therapeutics to address significant unmet medical needs in various diseases. The company leverages a proprietary platform to create these treatments.

Operating in the biotechnology sector, SAB Biotherapeutics Inc uses this proprietary platform to produce fully human polyclonal antibodies. With this, it develops effective therapies, particularly for infectious diseases and immune system disorders. This offers potential benefits for patients.

To keep an eye on how the stock is performing, add SABS to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.
CEO
Samuel J. Reich
Employees
86
Founded
2014
HQ
Miami Beach, Florida, US
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
What Is Leverage and Margin?
What Is Leverage and Margin?
Leverage means using capital borrowed from a broker when opening a position. Sometimes traders may wish to apply leverage in order to obtain more exposure than the amount deposited, as part of their investment strategy.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
Graph
Buy SAB Biotherapeutics Inc
Invest in SAB Biotherapeutics Inc
Today
Create an eToro account to buy SABS stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of SABS is ‎$‎3.70.
The average price target for SAB Biotherapeutics Inc is ‎$‎13.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for SAB Biotherapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of SAB Biotherapeutics Inc is ‎$‎282.92M
Based on 4 analysts offering recommendations for SABS in the last 3 months, the overall consensus is .
Scroll to top